Showing results (221-230 of 384) with videos related to
Sort By:
Pageof 39
Amino Acids|March 26, 2004
Cysteine-induced hypoglycemic brain damage: an alternative mechanism to excitotoxicityV Gazit, R Ben-Abraham, R Coleman, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 1999
Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? II. Olfactory quality discrimination in obsessive-compulsive disorderH Hermesh, J Zohar, A Weizman, et al.European Journal of Pharmacology|October 10, 1989
Chronic phenobarbital administration affects GABA and benzodiazepine receptors in the brain and peripheryA Weizman, F Fares, C G Pick, et al.Psychopharmacology|January 1, 1987
The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patientsA Weizman, I Gil-Ad, D Grupper, et al.Schizophrenia Research|October 12, 2001
Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatologyA M Ponizovsky, I Modai, Y Nechamkin, et al.Clinical Neuropharmacology|June 1, 1994
Verapamil is not an antidepressant in patients resistant to tricyclic antidepressantsS Adlersberg, P Toren, R Mester, et al.Journal of Psychiatry & Neuroscience : JPN|November 1, 1992
Delayed amnesia and disorientation after electroconvulsive treatmentA Grinshpoon, R Mester, B Spivak, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|December 16, 2014
The complex impact of five years of stress related to life-threatening events on pregnancy outcomes: a preliminary retrospective studyM Keren, N Keren, A Eden, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behaviorR Barzilay, T Lobel, A Krivoy, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|January 15, 2018
The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative studyR Weinberger, O Weisman, Y Guri, et al.Pageof 39